Stock Track | METIS TECHBIO-P Soars 5.53% Intraday on Strategic Partnership Announcement with Sandstone Biotech

Stock Track
05/18

METIS TECHBIO-P (07666) saw its stock price soar by 5.53% during intraday trading on Monday, marking a significant upward movement.

The surge appears to be driven by the company's announcement of a comprehensive strategic technology cooperation agreement with Sandstone Biotech, a firm specializing in tumor immunocellular therapy. The collaboration focuses on immune-targeted lipid nanoparticle (LNP) delivery technology, leveraging METIS TECHBIO-P's AI-powered NanoForge platform to advance next-generation in vivo immunotherapy products. This partnership is part of the company's OpenCGT initiative, which has now seen cumulative collaboration values exceed RMB 60 billion.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10